vimarsana.com
Home
Live Updates
Co-Diagnostics, Inc. Logix Smart™ COVID-19 2-Gene Tes
Co-Diagnostics, Inc. Logix Smart™ COVID-19 2-Gene Tes
Co-Diagnostics, Inc. Logix Smart™ COVID-19 2-Gene Test Approved for Use in the United Kingdom
/PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests,...
Related Keywords
United Kingdom ,
Utah ,
United States ,
Dwight Egan ,
Diagnostics Inc ,
Public Health England ,
United Kingdom Health Security Agency ,
Nasdaq ,
Logix Smart ,
Medical Devices ,
Coronavirus Test Device Approvals ,
Client Life Science ,
Co Diagnostics ,